1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-3650
  5. Product Images: Simvastatin

Product Images Simvastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Simvastatin NDC 70518-3650 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Footnote for Table 3 - Footnote for Table 3

Footnote for Table 3 - Footnote for Table 3

This text provides information on the chemical assay results for certain drugs, including CYP3A4 inhibitors such as ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. It also discusses the effects of grapefruit juice on the pharmacokinetics of simvastatin. However, it notes that the impact of different amounts of grapefruit juice has not been studied. The study involved administering grapefruit juice at different strengths and times with simvastatin.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Simvastatin is a medication that requires a prescription (RX ONLY) and is sold in tablet form with 90 tablets per container. The NDC number for this product is 70518-3650-00 and it has been repackaged by RemedyRepack Inc. Customers should keep the medication out of reach of children and ensure that it is stored between 20-25°C (68-77°F) with excursions permitted up to 15-30°C (59-86°F) [See USP]. The package insert should be consulted for directions on how to use the medication. The expiration date and lot number are not available.*

Figure 9 - simvastatin 10

Figure 9 - simvastatin 10

table2 - simvastatin 2

table2 - simvastatin 2

This is a table showing adverse reactions reported by patients treated with Simvastatin compared to placebo. The table lists various disorders such as edema/swelling, abdominal pain, atrial fibrillation, constipation, diabetes mellitus, myalgia, headache, insomnia, bronchitis, sinusitis, eczema, and urinary tract infection. The percentages of patients affected by these disorders are also mentioned.*

Structure - simvastatin 3

Structure - simvastatin 3

table 3 - simvastatin 4

table 3 - simvastatin 4

table 4 - simvastatin 5

table 4 - simvastatin 5

Figure 5 - simvastatin 6

Figure 5 - simvastatin 6

This appears to be a table with data related to the occurrence of major vascular and coronary events among patients with or without certain medical conditions who were treated with simvastatin or placebo. The table shows the number of patients, risk ratios, and confidence intervals for each group. However, because the table is incomplete and there are missing values and symbols, it is difficult to provide a full description.*

Figure 6 - simvastatin 7

Figure 6 - simvastatin 7

Figure 7 - simvastatin 8

Figure 7 - simvastatin 8

Figure 8 - simvastatin 9

Figure 8 - simvastatin 9

table 1 - table1

table 1 - table1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.